Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive-compulsive disorder: A double-blind randomized trial with placebo control

L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study

(2017) Somaye Arabzadeh et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Brain circuitry of compulsivity

(2016) Odile A. van den Heuvel et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial

(2016) K. Paydary et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial

(2016) Sophia Esalatmanesh et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study

(2016) Sahra Emamzadehfard et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Whole-genome association analysis of treatment response in obsessive-compulsive disorder

(2015) H Qin et al.   MOLECULAR PSYCHIATRY

N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review

(2015) Georgina Oliver et al.   Clinical Psychopharmacology and Neuroscience

Amantadine Augmentation Therapy for Obsessive Compulsive Patients Resistant to SSRIs—An Open-Label Study

(2014) Rafael Stryjer et al.   CLINICAL NEUROPHARMACOLOGY

A Psychological and Neuroanatomical Model of Obsessive-Compulsive Disorder

(2014) Edward D. Huey et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

The Effect of Riluzole Augmentation in a Patient With Treatment-Resistant Obsessive-Compulsive Disorder, Taking Two Other Glutaminergic Agents

(2014) Nahla Mahgoub et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

Obsessive–compulsive disorder: an integrative genetic and neurobiological perspective

(2014) David L. Pauls et al.   NATURE REVIEWS NEUROSCIENCE

Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study

(2014) Mohammad-Reza Khodaie-Ardakani et al.   PSYCHIATRY RESEARCH

N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease

(2013) David Olivares et al.   Current Alzheimer Research

Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept

(2013) Carolyn I Rodriguez et al.   NEUROPSYCHOPHARMACOLOGY

In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)

(2013) Mohammad Haghighi et al.   PSYCHOPHARMACOLOGY

Repeated Cortico-Striatal Stimulation Generates Persistent OCD-Like Behavior

(2013) S. E. Ahmari et al.   SCIENCE

Dopaminergic control of cognitive flexibility in humans and animals

(2013) Marianne Klanker et al.   Frontiers in Neuroscience

Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder

(2012) Neda Askari et al.   CNS DRUGS

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial

(2012) Ali Ghaleiha et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Evidence-based pharmacotherapy of obsessive-compulsive disorder

(2012) Naomi A. Fineberg et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study

(2012) Ali Ghaleiha et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder: a double-blind, placebo-controlled study

(2012) Antonio Bruno et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial

(2012) Mahtab Asadabadi et al.   PSYCHOPHARMACOLOGY

Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment

(2011) Christopher Pittenger et al.   PHARMACOLOGY & THERAPEUTICS

The role of glutamate signaling in the pathogenesis and treatment of obsessive–compulsive disorder

(2011) Ke Wu et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways

(2011) Mohammed R. Milad et al.   TRENDS IN COGNITIVE SCIENCES

Role of dopamine in the pathophysiology and treatment of obsessive–compulsive disorder

(2010) Min-Seong Koo et al.   Expert Review of Neurotherapeutics

Double-Blind, Placebo-Controlled Trial of Topiramate Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder

(2010) Heather A. Berlin et al.   JOURNAL OF CLINICAL PSYCHIATRY

Amantadine Augmentation for Refractory Obsessive-Compulsive Disorder

(2010) Massimo Pasquini et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders

(2010) Giles E. Hardingham et al.   NATURE REVIEWS NEUROSCIENCE

A family-based association study of the glutamate transporter geneSLC1A1in obsessive-compulsive disorder in 378 families

(2009) Y.Y. Shugart et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Obsessive-compulsive disorder

(2009) Jonathan S Abramowitz et al.   LANCET

Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive–Compulsive Disorder

(2009) Sagnik Bhattacharyya et al.   NEUROPSYCHOPHARMACOLOGY

Meta-Analysis of Brain Volume Changes in Obsessive-Compulsive Disorder

(2008) Jean-Yves Rotge et al.   BIOLOGICAL PSYCHIATRY

Effects of glutamate-related drugs on marble-burying behavior in mice: Implications for obsessive–compulsive disorder

(2008) Nobuaki Egashira et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication

(2008) A M Ruscio et al.   MOLECULAR PSYCHIATRY